Merck To Buy Acceleron Pharma For $11.5 Bln

Merck (MRK) on Thursday said it entered into a definitive agreement to buy Acceleron Pharma Inc. (XLRN) for about $11.5 billion or $180 per share, to be paid in cash.

As per the deal, Merck, through a subsidiary, is expected to initiate a tender offer to acquire all outstanding shares of Acceleron.

Acceleron's lead drug candidate, Sotatercept for the treatment of pulmonary arterial hypertension is in Phase 3 trials.

"Acceleron's innovative research has yielded an exciting late-stage candidate that complements and strengthens our growing cardiovascular portfolio and pipeline and holds the potential to build upon Merck's proud legacy in cardiovascular disease," said Rob Davis, chief executive officer and president, Merck.

Acceleron's portfolio also includes Reblozyl, which is being developed and commercialized in partnership with Bristol Myers Squibb, is approved in the United States, Europe, Canada and Australia for the treatment of anemia in adults with certain rare blood disorders.

The deal is expected to close in the fourth quarter of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT